Review: could Multiple myeloma cause Cutaneous lupus erythematosus?
We study 56,679 people who have Multiple myeloma from FDA and social media. Among them, 3 have Cutaneous lupus erythematosus. Find out below who they are, other conditions they have and drugs they take.
Stay connected: join a mobile support group for people who have Multiple myeloma and Cutaneous lupus erythematosus >>>
Multiple myeloma (latest reports from 133,763 patients) is typically treated by Revlimid, Velcade, Zometa, Thalomid, Dexamethasone Sodium Phosphate.
Cutaneous lupus erythematosus
Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms) (latest reports from 3,404 patients) has been reported by people with rheumatoid arthritis, high blood pressure, psoriasis, fungal nail infection, nail tinea.
On Jul, 22, 2014: 56,679 people who have multiple myeloma are studied. Among them, 3 (0.01%) have Cutaneous Lupus Erythematosus. They amount to 0.09% of all the 3,404 people who have Cutaneous Lupus Erythematosus on eHealthMe.
Gender of people who have multiple myeloma and experienced Cutaneous lupus erythematosus * :
|Cutaneous lupus erythematosus||100.00%||0.00% |
Age of people who have multiple myeloma and experienced Cutaneous lupus erythematosus * :
|Cutaneous lupus erythematosus||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||200.00% |
Severity of the symptom * :
Top co-existing conditions for these people * :n/a
Most common drugs used by these people * :
- Velcade (2 people, 66.67%)
- Revlimid (1 people, 33.33%)
- Carvedilol (1 people, 33.33%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
Get connected! Join a mobile support group:
- group for people who have Cutaneous Lupus Erythematosus and Multiple myeloma
- group for people who have Multiple myeloma
- group for people who have Cutaneous Lupus Erythematosus
Common treatments for Multiple Myeloma and their efficacy:
Could your drug cause it?
Comments from related studies:
From this study (6 months ago):
elevated alk phos, alt, ast & bilirubin. After removing micafungin 7 days ago and flagyl 3 days ago numbers starting to go down. Alk phos still increased slightly. Are drugs the cause?
From this study (8 months ago):
Neulasta was used after a 4-day course of VD-PACE (velcade, dexamethasone, doxorubicin, cisplatin, cytoxan, etoposide) to regenerate white blood cells. On day 5 after neulasta I had intense lower back pain in pulsating waves that lasted for 1 day. It was day 8 after treatment VD-PACE ended
4 weeks later the VD-PACE cycle was repeated. This time, in preparation for stem cell collection, I received daily high dose shots of of neupogen. On day 6 I started having the same lower back pain I now identified as kidney stones. It lasted for under 2 days and the EXTREMELY painful symptoms disappeared completely again. Symptoms started 8 days after VD-PACE treatment ended
From this study (8 months ago):
2-4 times a week. Soaked with sweat
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Multiple myeloma, Cutaneous lupus erythematosus
You may be interested at these reviews (what is this?):
- Velcade side effects
I have developed testicular pain after only seven injections of velcade,for my multiple myeloma. I am going to try to get my dosage of velcade reduced. I never had a problem in this area until this chemo medicine. I hope this helps other patients as my doctor never has heard of this side affect. ...
More reviews for: Multiple myeloma, Cutaneous lupus erythematosus
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.